Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Operating Leases (2022 - 2025)

Biodesix's Operating Leases history spans 4 years, with the latest figure at $24.0 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 3.18% year-over-year to $24.0 million; the TTM value through Dec 2025 reached $24.0 million, down 3.18%, while the annual FY2025 figure was $24.0 million, 3.18% down from the prior year.
  • Operating Leases reached $24.0 million in Q4 2025 per BDSX's latest filing, down from $24.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $25.5 million in Q2 2024 to a low of $1.2 million in Q1 2022.
  • Average Operating Leases over 4 years is $18.2 million, with a median of $24.3 million recorded in 2025.
  • Peak YoY movement for Operating Leases: skyrocketed 922.85% in 2023, then fell 5.37% in 2025.
  • A 4-year view of Operating Leases shows it stood at $5.3 million in 2022, then skyrocketed by 378.93% to $25.2 million in 2023, then dropped by 1.33% to $24.8 million in 2024, then dropped by 3.18% to $24.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Operating Leases are $24.0 million (Q4 2025), $24.4 million (Q3 2025), and $24.1 million (Q2 2025).